Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences
- PMID: 19543840
- DOI: 10.1007/s12020-009-9210-2
Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences
Erratum in
-
Erratum to: Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences.Endocrine. 2017 Jun;56(3):683. doi: 10.1007/s12020-016-1155-7. Endocrine. 2017. PMID: 27796810 No abstract available.
Abstract
Thyroid hormones are now recognized to change in different disease states with important consequences on severity and prognosis of disease. However, little is known about thyroid hormones' alterations in acute liver failure (ALF). To study the changes in thyroid hormones and cardiac thyroid receptors during ALF, we subjected seven female pigs to surgical liver devascularization. Liver function biochemical markers, thyroid hormones, endogenous opioids, malondialdehyde (MDA), and interleukins 1 and 6 were measured in serum for 24 h postoperatively. Heart biopsies were harvested at the end of the experiment. Baseline heart biopsies were taken from five additional animals. Serum thyroxin (T(4)) and triiodothyronine (T(3)) levels markedly decreased, whereas free-triiodothyronine and thyroxin-stimulating hormone levels did not change. T(4) and T(3) levels correlated with the degree of liver failure and with MDA and interleukin-6 levels. Beta-endorphin levels initially increased, whereas levels of leucine-enkephalin did not change. Thyroid hormone receptor-alpha1 protein expression in the heart decreased 1.6-fold after ALF, whereas myocardial myosin isoform expression remained unchanged. The downregulation of T(4) and T(3) levels during ALF seems to correlate well with the severity of disease. This downregulation related to inflammation and oxidative stress and resulted in changes in myocardial thyroid receptors.
Similar articles
-
Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery.Interact Cardiovasc Thorac Surg. 2010 Jan;10(1):76-80. doi: 10.1510/icvts.2009.213876. Epub 2009 Oct 12. Interact Cardiovasc Thorac Surg. 2010. PMID: 19822605 Clinical Trial.
-
Thyroid hormone receptor expression in the "sick euthyroid" syndrome.Lancet. 1989 Dec 23-30;2(8678-8679):1477-81. doi: 10.1016/s0140-6736(89)92930-9. Lancet. 1989. PMID: 2574767
-
Changes in thyroid function in patients with liver failure and their clinical significance: A clinical study of non-thyroidal illness syndrome in patients with liver failure.Hepatobiliary Pancreat Dis Int. 2020 Dec;19(6):561-566. doi: 10.1016/j.hbpd.2020.05.001. Epub 2020 May 28. Hepatobiliary Pancreat Dis Int. 2020. PMID: 32535064
-
Sick euthyroid syndrome. What to do when thyroid function tests are abnormal in critically ill patients.Postgrad Med. 1999 Apr;105(4):215-9. doi: 10.3810/pgm.1999.04.694. Postgrad Med. 1999. PMID: 10223098 Review.
-
[Non-thyroid illness" or changed thyroid hormone parameter syndrome with non-thyroid illnesses].Med Klin (Munich). 1998 Nov 15;93(11):662-8. doi: 10.1007/BF03044878. Med Klin (Munich). 1998. PMID: 9872043 Review. German.
Cited by
-
Assessment of thyroid and gonadal function in liver diseases.Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):89-94. doi: 10.4103/2230-8210.131761. Indian J Endocrinol Metab. 2015. PMID: 25593833 Free PMC article.
-
Occult endocrine dysfunction in patients with cirrhosis of liver.J Family Med Prim Care. 2016 Jul-Sep;5(3):576-580. doi: 10.4103/2249-4863.197293. J Family Med Prim Care. 2016. PMID: 28217586 Free PMC article.
-
Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver.Endocrine. 2015 Apr;48(3):942-8. doi: 10.1007/s12020-014-0364-1. Epub 2014 Jul 26. Endocrine. 2015. PMID: 25063309
-
The impact of serum thyroid-stimulation hormone levels on the outcome of hepatitis B virus related acute-on-chronic liver failure: an observational study.BMC Gastroenterol. 2022 Jul 7;22(1):330. doi: 10.1186/s12876-022-02406-7. BMC Gastroenterol. 2022. PMID: 35799116 Free PMC article.
-
Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases.Front Pharmacol. 2022 Jun 2;13:871100. doi: 10.3389/fphar.2022.871100. eCollection 2022. Front Pharmacol. 2022. PMID: 35721201 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources